The Toll-like receptor 4 antagonist TAK-242 in combination with sodium hyaluronate alleviates postoperative abdominal adhesion in a mouse model

被引:0
|
作者
Liu, Dong [1 ]
Tong, Haochongyang [2 ]
Guo, Yu [1 ]
Liu, Bin [1 ]
Ye, Changchun [2 ]
Yang, Ni [1 ]
Wu, Yunhua [1 ]
机构
[1] Shaanxi Prov Peoples Hosp, Dept Gen Surg 2, 256 West Youyi Rd, Xian 71000, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Gen Surg, Xian 710061, Shaanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
Toll-like receptor 4; TAK-242; Inflammation; Collagen deposition; Oxidative stress; PREVENTION; MECHANISMS; STRATEGIES; SURGERY;
D O I
10.1186/s12920-024-02031-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Postoperative abdominal adhesion is one of the most common complications after abdominal surgery. The Toll-like receptor 4 (TLR4) signaling pathway is one of the most common inflammation-related pathways, and it has been demonstrated that TLR4 is highly expressed in adhesive tissues; however, the function of TLR4 in adhesion formation has not yet been studied. In the present study, the expression of TLR4 was first detected by immunohistochemical (IHC) and double-immunofluorescence staining in 40 mice, which were randomly divided into four groups, and sacrificed at 1, 3, 5 and 7 days after surgery. Subsequently, another 40 mice were randomly divided into five groups; with the exception of the sham group, the other groups were modeled and treated with saline that contained DMSO, sodium hyaluronate (HA), TAK-242 or TAK-242 + HA (applied to damaged peritoneal wounds). A total of 7 days after surgery, the mice were sacrificed and specimens were collected. Inflammation was detected by hematoxylin and eosin staining, and ELISA of transforming growth factor- beta 1 (TGF-beta 1) and interleukin-6 (IL-6); collagen deposition was examined by Masson staining and IHC staining of alpha-SMA; and reactive oxygen species (ROS) were detected by ROS staining and malondialdehyde (MDA) assay. The results revealed that TLR4 was highly expressed in the adhesive tissues at 3, 5 and 7 days after surgery. In addition, TAK-242 + HA treatment could reduce abdominal adhesion formation, exhibiting lower Nair's score and inflammation scores, lower TGF-beta 1 and IL-6 levels, and lower collagen thickness and alpha-SMA levels compared with those in the control group. In addition, the TAK-242 + HA group had lower levels of ROS and MDA compared with those in the control group. The present study revealed that TLR4 was highly expressed in the process of adhesion formation and its inhibitor, TAK-242, combined with HA, could reduce adhesion formation by reducing inflammation and ROS, and alleviating collagen deposition.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] TAK-242, a specific inhibitor of Toll-like receptor 4 signalling, prevents endotoxemia-induced skeletal muscle wasting in mice
    Yuko Ono
    Yuko Maejima
    Masafumi Saito
    Kazuho Sakamoto
    Shoichiro Horita
    Kenju Shimomura
    Shigeaki Inoue
    Joji Kotani
    Scientific Reports, 10
  • [32] Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
    S. Fan
    Y. Liao
    W. Qiu
    L. Li
    D. Li
    X. Cao
    B. Ai
    Clinical and Translational Oncology, 2020, 22 : 2074 - 2086
  • [33] Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
    Fan, S.
    Liao, Y.
    Qiu, W.
    Li, L.
    Li, D.
    Cao, X.
    Ai, B.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (11): : 2074 - 2086
  • [34] Toll-Like Receptor 4 Inhibitor TAK-242 Augments Acetylcholine Induced Relaxation in Superior Mesenteric Arteries of the Streptozotocin-Induced Diabetic Rat
    Matsumoto, Takayuki
    Takayanagi, Keisuke
    Kojima, Mihoka
    Taguchi, Kumiko
    Kobayashi, Tsuneo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (08) : 1283 - 1287
  • [35] Toll-like receptor 4 signaling pathway is correlated with pathophysiological characteristics of AML patients and its inhibition using TAK-242 suppresses AML cell proliferation
    Baakhlagh, Sedigheh
    Kashani, Bahareh
    Zandi, Zahra
    Bashash, Davood
    Moradkhani, Malihe
    Nasrollahzadeh, Ali
    Yaghmaei, Marjan
    Mousavi, Seyed A.
    Ghaffari, Seyed H.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 90
  • [36] TAK-242, a novel Toll-like receptor 4 signal transduction inhibitor, protects mice in Escherichia coli-induced and lipoteichoic acid-induced lethality models
    M Ii
    M Sunamoto
    M Uekata
    J Sato
    T Kitazaki
    Y Iizawa
    Critical Care, 10 (Suppl 1):
  • [37] The toll like receptor-4 antagonist, TAK-242, enhances repair of ultraviolet radiation-induced DNA damage and inhibits UVB-induced tumor development in mice
    Sherwani, M. A.
    Abdelgawad, A. S.
    Eraslan, M.
    Chung, M.
    Elmets, C.
    Yusuf, N.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S89 - S89
  • [38] Hepatic inflammation-senescence-regeneration gene expression during recovery from ACLF and the effect of granulocyte-colony stimulating factor (GCSF), toll-like receptor-4 (TAK-242) inhibition and their combination (G-TAK)
    Saeidinejad, MohammadMahdi
    Shaw, Daniel
    Engelmann, Cornelius
    Habtesion, Abeba
    Andreola, Fausto
    Jalan, Rajiv
    JOURNAL OF HEPATOLOGY, 2024, 80 : S182 - S183
  • [39] TAK-242, a small-molecule inhibitor of Toll-like receptor 4 signalling, unveils similarities and differences in lipopolysaccharide- and lipid-induced inflammation and insulin resistance in muscle cells
    Hussey, Sophie E.
    Liang, Hanyu
    Costford, Sheila R.
    Klip, Amira
    DeFronzo, Ralph A.
    Sanchez-Avila, Alicia
    Ely, Brian
    Musi, Nicolas
    BIOSCIENCE REPORTS, 2013, 33 : 37 - U56
  • [40] TAK-242, a Small-Molecule Inhibitor of Toll-Like Receptor-4 Signaling, Protects Against Lipopolysaccharide- and Lipid-Induced Inflammation and Insulin Resistance in Muscle Cells
    Hussey, Sophie E.
    Defronzo, Ralph A.
    Sanchez-Avila, Alicia
    Musi, Nicolas
    DIABETES, 2012, 61 : A472 - A472